3 completed, 1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow CBLB502: new trials by email Literature Review of CBLB502 trials Research Report on CBLB502
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination Entolimod, Placebo, Influenza vaccine - Healthy | Phase 2 | Completed | Robert J. Pignolo | 61 | 2019-10-30 | 2023-06-22 |
| Entolimod, an Adjuvant for Vaccine Augmentation Entolimod, Td Vaccine - Substance Use Disorders | Early Phase 1 | Completed | Baylor College of Medicine | 40 | 2017-12-08 | 2020-09-01 |
| Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer CBLB502, Placebo - Colorectal Cancer | Phase 2 | Unknown | BioLab 612 LLC | 40 | 2015-11-01 | 2017-02-09 |
| Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy entolimod, intensity-modulated radiation therapy, cisplatin - Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2014-01-01 | 2013-12-11 | |
| Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery entolimod, pharmacological study, laboratory biomarker analysis - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Roswell Park Cancer Institute | 25 | 2012-01-01 | 2022-07-22 |
Colorectal Neoplasms (1) · Influenza, Human (1) · Mucositis (1) · Squamous Cell Carcinoma of Head and Neck (1) · Substance-Related Disorders (1) · Tongue Neoplasms (1)
Roswell Park Cancer Institute (2) · Baylor College of Medicine (1) · BioLab 612 LLC (1) · Robert J. Pignolo (1)
United States (3) · Russia (1)
Alex Adjei (1) · Anurag Singh (1) · Nikolay V. Kislov, MD PhD (1) · Robert Pignolo, MD, PhD (1) · Sergei I. Achkasov, MD PhD (1) · Sergei V. Odintcov, MD PhD (1) · Thomas Kosten, MD (1)